Developmental toxicity in rat fetuses exposed to the benzimidazole netobimin

Reproductive Toxicology

Volumn 13, Issue 4, 1999, Pages 295-302

  Navarro, Marc ^a   Canut, Lourdes ^b   Carretero, Ana ^a   Cristofol, Carles ^a   Pérez Aparicio, Fco Javier ^a   Arboix, Margarida ^a   Ruberte, Jesús ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Lab Teratology CIDA (Ctro I   (Spain)

Author keywords

Benzimidazoles; Corrosion casting; Dysmorphogenesis; Embryolethality; Pathogenesis of malformations; Rat fetus; Scanning electron microscopy; Teratology

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; GUANIDINE DERIVATIVE; NETOBIMIN; PRODRUG;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MALFORMATION; CONGENITAL BLOOD VESSEL MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETOTOXICITY; FETUS; FETUS DEVELOPMENT; FETUS RESORPTION; IATROGENIC DISEASE; MALE; MUSCULOSKELETAL SYSTEM MALFORMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PREGNANCY; RAT; RAT STRAIN; RIB MALFORMATION; SKELETON MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; CARDIOVASCULAR ABNORMALITIES; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL RESORPTION; GUANIDINES; MALE; MUSCULOSKELETAL ABNORMALITIES; PREGNANCY; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0033166084     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(99)00013-1     Document Type: Article

References (35)

1. Delatour P., Cure M.C., Benoit E., Garnier F. Netobimin (Totabin-SHC) preliminary investigations on metabolism and pharmacology . J Vet Pharmacol Ther. 9:1986;230-234.
2. Theodorides V.J., Gyurik R.J., Kingsbury W.D., Parish R.C. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia. 32:1976;702-703.
3. Marriner S.E., Morris D.L., Dickson B., Bogan J.A. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol. 30:1986;705-708.
4. Morris D.L., Dykes P.W., Dickson B., Marriner S.E., Bogan J.A., Burrows F.G.O. Albendazole in hydatid disease. Br Med J. 286:1983;103-104.
5. Navarro M., Cristofol C., Carretero A., Arboix M., Ruberte J. Congenital malformations induced by an anthelmintic (Netobimin) in sheep embryos. Vet Rec. 140:1998;86-90.
6. Lacey E., Watson T.R. Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. Biochem Pharmacol. 34:1985;1073-1077.
7. Gyurik R.J., Chow A.W., Zaber B., Bruneer E.L., Miller J.A., Villani A.J., Petkam L.A., Parish R.C. Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab Dispos. 9:1981;503-508.
8. Delatour P., Parish R.C., Gyurik R.J. Albendazole a comparison of relay embryotoxicity with embryotoxicity of individual metabolites . Ann Rech Vet. 12:1981;159-167.
9. Delatour P., Garnier F., Benoit E., Longin C.H. A correlation of albendazole and oxfendazole with their free metabolites and bound residues. J Vet Pharmacol Ther. 7:1984;139-145.
10. Cristofol C., Navarro M., Franquelo C., Valladares J.E., Carretero A., Ruberte J., Arboix M. Disposition of Netobimin, albendazole and its metabolites in the pregnant rat developmental toxicity . Toxicol Appl Pharmacol. 144:1997;56-61.
11. Cristofol C., Carretero A., Fernandez M., Navarro M., Sautet J., Ruberte J., Arboix M. Transplacental transport of Netobimin metabolites in ewes. Eur J Drug Metab Pharmacokinetics. 20:1995;167-171.
12. Lapras M., Delatour P., Deschanel J.P., Lorgue G., Camps S., Regnier B. Etude expérimentale de l'activité tèratogène du parbendazole chez le rat. B Soc Sci Vet Med Comp. 75:1973;117-130.
13. Mantovani A., Ricciardi C., Stazi A., Macri C. Effects observed on Gestational Day 13 in rat embryos exposed to albendazole. Reprod Toxicol. 9:1995;265-273.
14. Yoshimura H. Teratogenicity of flubendazole in rats. Toxicology. 43:1987;133-138.
15. Staples R.E., Schnell V.L. Refinements in rapid clearing technic in the KOH-Alizarin red S method for fetal bone. Stain Tech. 39:1964;61-63.
16. Carretero A., Ditrich H., Splechtna H., Navarro M., Ruberte J. Technical improvements in corrosion casting of small specimens a study on mesonephric tubules and vessels of chicken embryos . Scanning Microsc. 7:1993;1333-1338.
17. Hodde K.C., Nowell J.A. SEM of micro-corrosion casts. Scanning Electron Microsc. II:1980;89-106.
18. Navarro M., Carretero A., Canut L., Pérez-Aparicio F.J., Cristofol C., Manesse M., Sautet J., Arboix M., Ruberte J. Injection technique and SEM study of the arterial pattern of the 20 Gestation Days (G20) rat fetus. Lab Anim. 32:1998;95-105.
19. Wise L.D., Beck S.L., Beltrame D., Beyer B.K., Chahoud I., Clark R.L., Clark R., Druga A.M., Feuston M.H., Guittin P., Henwood S.M., Kimmel C.A., Lindstrom P., Palmer A.K., Petrere J.A., Solomon H.M., Yasuda M., York R.G. Terminology of developmental abnormalities in common laboratory mammals (Version 1). Teratology. 55:1997;249-292.
20. Nomina Anatomica Veterinaria. Nomina Embryologica Veterinaria. International Committees on Veterinary Gross Anatomical Nomenclature. Under the financial responsibility of the World Association of Veterinary Anatomists. Zürich and Ithaca, New York; 1994.
21. Szabo K.T. Congenital malformations in laboratory and farm animals. 1989;Academic Press. Inc, San Diego.
22. Kimmel C.A., Wilson J.G. Skeletal deviations in rats malformations or variations? Teratology. 8:1973;309-316.
23. Beyer P.E., Chernoff N. The induction of supernumerary ribs in rodents role of maternal stress . Teratog Carcinog Mutag. 6:1986;419-429.
24. Duncan W.A.M., Lemon P.G. The effects of methyl-5(6)-butyl-2-benzimidazole carbamate (parbendazole) on reproduction in sheep and other animals. VIII. Teratogenicity in the rat. Cornell Vet. 64:(Suppl. 4):1974;97-103.
25. Kessel M. Respecification of vertebral identities by retinoic acid. Development. 115:1992;487-501.
26. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845-848.
27. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 114:1992;521-532.
28. Harada S., Nagy J.A., Sullivan K.A., Thomas K.A., Endo N., Rodan G.A., Rodan S.B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest. 93:1994;2490-2496.
29. Goad D.L., Rubin J., Tashjian A.H., Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblasts-like cells and murine osteoblasts by insuline-like growth factor I. Endocrinology. 137:1996;2262-2268.
30. Whittaker S.G., Faustman E.M. Effects of albendazole sulfoxide on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol. 109:1991;73-84.
31. Whittaker S.G., Faustman E.M. Effects of benzimidazole analogs on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol. 113:1992;144-151.
32. Wang D.S., Miura M., Demura H., Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology. 138:1997;2953-2962.
33. Schlaeppi J.M., Gutzwiller S., Finkenzeller G., Fournier B. 1,25-dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res. 23:1997;213-229.
34. Kirby M.L. Cellular and molecular contributions of the cardiac neural crest to cardiovascular development. Trends Cardiovasc Med. 3:1993;18-23.
35. Nathan H., Barkay M., Orda R. Anatomical observations on the origin and course of the aortic intercostal arteries. J Thorac Cardiovasc Surg. 59:1970;372-375.